Medicus Pharma Ltd. MDCX
1.84 USD -0.19 (-9.36%)
Nov 4, 2026, 2:15 PM EST
1.71 Day range 2.16
1.84 52-week range 121.00
- YTD
- -97.59%
- 1 year
- -98.33%
Financial health
Altman Z-Score
-10.80 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 2
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -0.8×
FY 2021 5y median -5.4× FY 2025
P/S 0.0×
FY 2021 5y median 0.0× FY 2025
P/B -391×
FY 2021 5y median -1.8× FY 2025
P/FCF -1.2×
FY 2021 5y median -5.1× FY 2025
EV/EBITDA -0.9×
FY 2021 5y median -2.2× FY 2025
EV/Sales 0.0×
FY 2021 5y median 0.0× FY 2025
FCF Yield -86.1%
FY 2021 5y median -19.4% FY 2025
Profitability
Gross Margin 0.0%
FY 2021 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2021 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2021 5y median 0.0% FY 2025
ROE 37549.8%
FY 2021 5y median 13.9% FY 2025
ROIC -452.4%
FY 2021 5y median -323.4% FY 2025
ROA -252.1%
FY 2021 5y median -280.8% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2021 FY 2025
Operating Income -64.1%
FY 2021 FY 2025
EPS (diluted) -184.1%
FY 2021 FY 2025
Free Cash Flow -122.3%
FY 2021 FY 2025
Financial Health
Current Ratio 1.0×
FY 2021 5y median 1.0× FY 2025
Quick Ratio 1.0×
FY 2021 5y median 1.0× FY 2025
Debt / Equity -59.1×
FY 2021 5y median -0.1× FY 2025
Net Debt / EBITDA 0.2×
FY 2021 5y median -0.3× FY 2025
Interest Coverage -130×
FY 2021 5y median -12.5× FY 2025
Dividends
Dividend Yield 0.0%
FY 2021 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2021 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31